Case number 1:22-cv-00909
Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2023 | 71 | NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 07/03/2023) (1) |
| Jun 16, 2023 | 70 | NOTICE OF SERVICE of Defendants' Second Amended Initial Invalidity Contentions filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 06/16/2023) (1) |
| Jun 6, 2023 | 69 | ORDER: The telephone status conference, scheduled for June 8, 2023 at 2:00 p.m., is CANCELED. Signed by Judge Joshua D. Wolson on 06/06/2023. (smg) (Entered: 06/06/2023) (1) |
| Jun 5, 2023 | 68 | Joint Letter to The Honorable Joshua D. Wolson regarding Status Report - re 52 Terminate Hearings,, Order Setting Teleconference,. (Tigan, Jeremy) (Entered: 06/05/2023) (1) |
| Jun 2, 2023 | 67 | NOTICE OF SERVICE of Plaintiff's Opening Markman Brief filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 06/02/2023) (3) |
| May 26, 2023 | 66 | NOTICE OF SERVICE of Defendants Second Supplemental Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 05/26/2023) (1) |
| May 26, 2023 | 65 | NOTICE OF SERVICE of Veloxis's Objections and Responses to Accord's Fourth Set of Requests for Production of Documents and Things (RFP No. 19) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 05/26/2023) (3) |
| May 15, 2023 | 64 | NOTICE OF SERVICE of Veloxis's Objections and Responses to Accord's Third Set of Requests for Production of Documents and Things (RFP Nos. 17-18) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 05/15/2023) (3) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit F - Portions of File History of U.S. Patent No. 8,664,239) (18) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit E - Portions of File History of U.S. Patent No. 8,685,998) (30) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit D - Portions of File History of U.S. Patent No. 11,110,081) (30) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit C - Portions of File History of U.S. Patent No. 10,864,199) (30) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit B - U.S. Patent No. 11,110,081) (30) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Exhibit A - U.S. Patent No. 10,864,199) (30) |
| May 5, 2023 | 63 | CLAIM Construction Chart by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit C - Portions of File History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,081, # 5 Exhibit E - Portions of File History of U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan, Jeremy) (Entered: 05/05/2023) (Main Document) (5) |
| May 5, 2023 | 62 | SO ORDERED, D.I. 61 STIPULATION and [Proposed] Order Concerning Claim Construction of U.S. Patent Nos. 8,685,998; 9,549,918; 10,864,199; 11,110,081; 11,123,331; and 11,419,823. Signed by Judge Joshua D. Wolson on 05/05/2023. (smg) (Entered: 05/05/2023) (3) |
| May 4, 2023 | 61 | STIPULATION and [Proposed] Order Concerning Claim Construction of U.S. Patent Nos. 8,685,998; 9,549,918; 10,864,199; 11,110,081; 11,123,331; and 11,419,823 by Veloxis Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/04/2023) (3) |
| Apr 26, 2023 | 60 | NOTICE OF SERVICE of Accords Fourth Set of Requests for Production of Document and Things (No. 19) filed by Accord Healthcare, Inc..(Metzler, Sara) (Entered: 04/26/2023) (1) |
| Apr 21, 2023 | 59 | NOTICE OF SERVICE of Plaintiff's Preliminary Proposed Claim Constructions filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 04/21/2023) (3) |
| Apr 20, 2023 | 58 | NOTICE OF SERVICE of Defendants' Responses to Plaintiffs Third Set of Requests for Production (Nos. 73-74) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 04/20/2023) (1) |
| Apr 13, 2023 | 57 | NOTICE OF SERVICE of Accord's Third Set of Requests for Production of Documents and Things (Nos. 17-18) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 04/13/2023) (1) |
| Apr 10, 2023 | 56 | NOTICE OF SERVICE of Defendants Identification of Terms and Phrases for Claim Construction filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 04/10/2023) (1) |
| Apr 7, 2023 | 55 | NOTICE OF SERVICE of Plaintiff's Preliminary Proposed Terms for Claim Construction filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 04/07/2023) (3) |
| Apr 5, 2023 | 54 | NOTICE OF SERVICE of Defendants' Responses to Plaintiff's Second Set of Requests for Production (Nos. 71-72) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 04/05/2023) (1) |
| Apr 3, 2023 | 53 | NOTICE OF SERVICE of Veloxis's Objections and Responses to Defendants' First Set of Rule 33 Interrogatories (Nos. 1-2) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 04/03/2023) (3) |
| Mar 30, 2023 | 52 | ORDER: The telephone status conference, scheduled for today, March 30, 2023 at 3:00 p.m., is RESCHEDULED for June 8, 2023, at 2:00 p.m. The Court will provide the Parties with a dial-in number in advance of the call. The Parties are directed to submit a joint letter to the Court on or before June 5, 2023, outlining any issues to be discussed on the call. Signed by Judge Joshua D. Wolson on 03/30/2023. (smg) (Entered: 03/30/2023) (1) |
| Mar 29, 2023 | 51 | NOTICE OF SERVICE of (1) Defendants Amended Initial Invalidity Contentions and (2) Defendants First Supplemental Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 03/29/2023) (1) |
| Mar 28, 2023 | 50 | Joint Letter to The Honorable Joshua D. Wolson regarding Status Report - re 40 Order,,,,,. (Tigan, Jeremy) (Entered: 03/28/2023) (1) |
| Mar 27, 2023 | 49 | NOTICE OF SERVICE of Veloxis's Objections and Responses to Accord's Second Set of Requests for Production of Documents and Things (RFP Nos. 14-16) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 03/27/2023) (3) |
| Mar 22, 2023 | 48 | Letter to The Honorable Joshua D. Wolson from Jeremy A. Tigan regarding Request to Excuse Andrew Berdon, Esq. from the March 30, 2023 Status Conference. (Tigan, Jeremy) (Entered: 03/22/2023) (1) |
| Mar 21, 2023 | 47 | NOTICE OF SERVICE of Plaintiff's Third Set of Requests for Production of Documents and Things to All Defendants (Nos. 73-74) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 03/21/2023) (3) |
| Mar 17, 2023 | 46 | NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 03/17/2023) (1) |
| Mar 2, 2023 | 45 | NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production of Documents and Things to All Defendants (Nos. 71-72) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 03/02/2023) (3) |
| Mar 2, 2023 | 44 | NOTICE OF SERVICE of Defendants First Set of Rule 33 Interrogatories (Nos. 1-2) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Farnan, Kelly) (Entered: 03/02/2023) (1) |
| Feb 24, 2023 | 43 | NOTICE OF SERVICE of Accord's Second Set of Requests for Production of Documents and Things (RFP Nos. 14-16) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 02/24/2023) (1) |
| Feb 17, 2023 | 42 | NOTICE OF SERVICE of Veloxis's Initial Infringement Contentions and Claim Charts filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 02/17/2023) (3) |
| Feb 8, 2023 | 41 | NOTICE OF SERVICE of (1) Defendants' Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) and (2) Defendants' Responses to Plaintiff's First Set of Requests for Production (Nos. 1-70) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Metzler, Sara) (Entered: 02/08/2023) (1) |
| Jan 31, 2023 | 40 | ORDER, The Parties shall narrow their claims in this case as follows: On or before February 17, 2023, Plaintiff shall narrow the scope of its claims to 10 claims per patent and 50 total claims. Twenty-eight days after the Court's claim construction order, Plaintiff shall further narrow the scope of it claims to five claims per patent and 25 total claims. On or before March 17, 2023, Defendant shall narrow its invalidity contentions to 12 references or combinations per patent and 50 total references or combinations. Twenty-eight days after the Court's claim construction order, Defendant shall further narrow its invalidity contentions to six references or combinations per patent and 25 total references or combinations. The Court's prior Scheduling Order (D.I. 24 ) is AMENDED such that the bench trial scheduled for April 8, 2024, will take place in Courtroom 12B, United States District Court, 601 Market Street, Philadelphia, PA 19106. The Court will hold a telephone status conference on March 30, 2023, at 1:00 p.m. EDT. The Court will provide the parties a dial-in number in advance of that call. The Parties shall submit a joint letter to the Court on or before March 28, 2023 outlining any issues to be discussed on the call. Signed by Judge Joshua D. Wolson on 1/31/2023. (apk) (Entered: 01/31/2023) (10) |
| Jan 30, 2023 | 39 | NOTICE OF SERVICE of Veloxis's Objections and Responses to Accord's First Set of Requests for Production of Documents and Things (RFP Nos. 1-13) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 01/30/2023) (3) |
| Jan 25, 2023 | 38 | Joint Letter to The Honorable Joshua D. Wolson from Jeremy A. Tigan regarding Status Report - re 37 Order, Scheduling Notice. (Tigan, Jeremy) (Entered: 01/25/2023) (3) |
| Jan 19, 2023 | 37 | ORDER, the telephone status conference scheduled for January 27, 2023 at 2:00 p.m. is RESCHEDULED for January 31, 2023, at 12:30 p.m. Signed by Judge Joshua D. Wolson on 1/19/2023. (srs) (Entered: 01/19/2023) (1) |
| Jan 9, 2023 | 36 | NOTICE requesting Clerk to remove Aaron F. Barkoff as co-counsel. Reason for request: Left firm. (Metzler, Sara) (Entered: 01/09/2023) (1) |
| Jan 9, 2023 | 35 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories (Nos. 1-6) and (2) Plaintiff's First Set of Requests for Production of Documents and Things to All Defendants (Nos. 1-70) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 01/09/2023) (3) |
| Dec 30, 2022 | 34 | NOTICE OF SERVICE of First Set of Requests for Production of Documents and Things (Nos. 1-13) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Farnan, Kelly) (Entered: 12/30/2022) (1) |
| Dec 28, 2022 | 33 | ORDER granting 32 Motion to Appear Pro Hac Vice. Signed by Judge Joshua D. Wolson on 12/28/2022. (apk) (Entered: 12/28/2022) (3) |
| Dec 27, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Rajendra A. Chiplunkar - filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd.. (Metzler, Sara) (Entered: 12/27/2022) (3) |
| Dec 23, 2022 | 31 | NOTICE OF SERVICE of Veloxis Pharmaceuticals, Inc.'s Identification of Asserted Patents and Accused Products filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/23/2022) (3) |
| Nov 28, 2022 | 30 | PROTECTIVE ORDER. Signed by Judge Joshua D. Wolson on 11/28/2022. (twk) (Entered: 11/28/2022) (19) |
| Nov 23, 2022 | 29 | NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Farnan, Kelly) (Entered: 11/23/2022) (1) |
| Nov 23, 2022 | 28 | NOTICE OF SERVICE of Veloxis Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/23/2022) (3) |
| Nov 23, 2022 | 27 | ANSWER to 25 Answer to Amended Complaint, Counterclaim by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/23/2022) (16) |
| Nov 22, 2022 | 26 | Joint MOTION for Protective Order - filed by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Ex. A- Proposed Protective Order)(Tigan, Jeremy) (Entered: 11/22/2022) (Ex. A- Proposed Protective Order) (19) |
| Nov 22, 2022 | 26 | Joint MOTION for Protective Order - filed by Veloxis Pharmaceuticals, Inc.. (Attachments: # 1 Ex. A- Proposed Protective Order)(Tigan, Jeremy) (Entered: 11/22/2022) (Main Document) (3) |
| Nov 4, 2022 | 25 | ANSWER to Amended Complaint, re: 20 Amended Complaint , COUNTERCLAIM against Veloxis Pharmaceuticals, Inc. by Intas Pharmaceuticals Ltd., Accord Healthcare, Inc..(Metzler, Sara) (Entered: 11/04/2022) (30) |
| Oct 28, 2022 | 24 | SCHEDULING ORDER: Joinder of Parties due by 11/18/2022. Amended Pleadings due by 11/18/2022. Discovery due by 1/26/2024. Opening Expert Reports due by 11/17/2023. Rebuttal Expert Reports due by 12/22/2023. A Status Conference is set for 1/27/2023 at 02:00 PM before Judge Joshua D. Wolson Claim Construction Opening Brief due by 6/2/2023. Claim Construction Answering Brief due by 7/1/2023. Claim Construction Reply Brief due by 7/21/2023. Claim Construction Surreply Brief due by 8/4/2023. Joint Claim Construction Brief due by 8/18/2023. A Markman Hearing is set for 9/28/2023 at 10:00 AM in Philadelphia before Judge Joshua D. Wolson. A Final Pretrial Conference is set for 3/21/2024 at 10:00 AM in Philadelphia before Judge Joshua D. Wolson. A 5-Day Bench Trial is set for 4/8/2024 at 09:30 AM before Judge Joshua D. Wolson.(See Order for further details) Signed by Judge Joshua D. Wolson on 10/28/2022. (smg) Modified on 10/28/2022 (smg). (Entered: 10/28/2022) (9) |
| Oct 26, 2022 | 23 | NOTICE OF SERVICE of Defendants Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Farnan, Kelly) (Entered: 10/26/2022) (1) |
| Oct 26, 2022 | 22 | NOTICE OF SERVICE of Veloxis Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Veloxis Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 10/26/2022) (3) |
| Oct 14, 2022 | 21 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2 ;9,549,918 B2 ;10,166,190 B2 ;10,864,199 B2 ;11,110,081 B2 ;11,123,331 B2 ;11,419,823 B2 (Amended). (Tigan, Jeremy) (Entered: 10/14/2022) (2) |
| Oct 14, 2022 | 20 | Complaint* (1) |
| Jul 22, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Veloxis Pharmaceuticals, Inc.: For Intas Pharmaceuticals Ltd. waiver sent on 7/11/2022, answer due 9/9/2022. (Tigan, Jeremy) |
| Jul 22, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Veloxis Pharmaceuticals, Inc.: For Accord Healthcare, Inc. waiver sent on 7/11/2022, answer due 9/9/2022. (Tigan, Jeremy) |
| Jul 15, 2022 | 7 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, James E. Baker and Anastasia M. Fernands - filed by Veloxis Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Jul 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, James E. Baker and Anastasia M. Fernands filed by Veloxis Pharmaceuticals, Inc. Ordered by Judge Maryellen Noreika on 7/15/2022. (asw) |
| Jul 13, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Jul 7, 2022 | 1 | Complaint* (1) |
| Jul 7, 2022 | 6 | Summons Issued (2) |
| Jul 7, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to Accord Healthcare, Inc. on 7/7/2022; Intas Pharmaceuticals Ltd. on 7/7/2022. (Attachments: # (1) Summons Issued)(srs) |
| Jul 7, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Asahi Kasei Corp. for Veloxis Pharmaceuticals, Inc. filed by Veloxis Pharmaceuticals, Inc. (srs) |
| Jul 7, 2022 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2 ; 9,549,918 B2; 10,166,190 B2; 10,864,199 B2; 11,110,081 B2; 11,123,331 B2. (srs) |
| Jul 7, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/26/2022. Date of Expiration of Patent: See Attached Form.Thirty Month Stay Deadline: 11/26/2024. (srs) |
| Jul 7, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jul 7, 2022 | 1 | Civil Cover Sheet (1) |
| Jul 7, 2022 | 1 | Exhibit A-G (275) |
| Jul 7, 2022 | 1 | Main Document (20) Docket Text: COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Ltd. ( Filing fee $ 402, receipt number ADEDC-3911285.) - filed by Veloxis Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A-G, # (2) Civil Cover Sheet)(srs) |
